🔎 Trials Near Me

Home › Mga Sakit sa Dugo › Texas

Pag-aaral pangklinika para sa Mga Sakit sa Dugo sa Texas

10 pag-aaral para sa Mga Sakit sa Dugo ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • Texas Childrens Cancer and Hematology Center, Houston
  • U of TX Health Science Ct, Houston
Nagre-recruitPhase 3
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06439082

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • Quetzal Site 6, Houston
Nagre-recruitPhase 3
Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07504458

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Baylor College of Medicine, Houston
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06722235

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • The University of Texas MD Anderson Cancer Center, Houston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04996875

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Baylor College of Medicine, Houston
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06948318

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Children's Blood and Cancer Center of Central Texas, Austin
  • North Texas Hemophilia and Thrombosis Program - Pediatric Program / Center for Cancer & Blood Disorders, Dallas
  • North Texas Comprehensive Hemophilia Treatment Center, Dallas
  • at 3 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04398628

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  • Lumi Research, Kingwood
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05254743

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • University of Texas Southwestern Medical Center, Dallas
  • MD Anderson Cancer Center, Houston
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT04256317

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

  • The University of Texas MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2025 · NCT05423691

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

  • MD Anderson Cancer Center, Houston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 15, 2024 · NCT06034275

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.